CBPE in exclusivity to acquire Palatine-backed Veincentre
Midmarket sponsor CBPE is in exclusivity to acquire Palatine-backed Veincentre, according to two sources familiar with the situation.
More on Exits
SGT Capital to acquire Summit-backed Elatec for EUR 400m
Mid-market sponsor looks to grow company via “continued technical innovation” and international expansion
Egeria to exit GoodLife Foods in SBO to IK Partners
Acquisition of Dutch frozen snack maker marks 13th investment from IK IX Fund
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt
Inflexion kicks off Rosemont Pharmaceuticals sale
Liquid pharmaceuticals manufacturer has drawn strategic and PE interest ahead of non-binding offers
Latest News
Adams Street secures USD 3.2bn for newest secondaries programme amid LP stakes dealflow uptick
Private markets investor has seen LP stakes increase as a proportion of its deployment over the past year, partner Jeff Akers said
Purple Ventures plans EUR 30m-EUR 40m fund to invest across CEE
Early-stage investor expects to hold a EUR 20m-plus first close for its second fund by Q1 2024
Bewater Funds nears EUR 7m close for second fund, aims to back 20 companies in next four years
Bewater II FCRE takes minority stakes (5%-25%) with tickets of EUR 500,000-EUR 2m, and it has already made three investments.
Unquote Private Equity Podcast: In conversation with... Fabio Ranghino, Ambienta
In an interview with Unquote, Ranghino discusses topics including ESG and the next phase of Ambienta’s growth